다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Nymox Pharmaceutical Corp (NYMX)
Nymox Pharmaceutical Corp (NYMX) 뉴스

NYMX

Nymox Pharmaceutical (NYMX)

Nymox Pharmaceutical Corp

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NYMX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/29	02:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/11/10	02:55	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/11/06	23:59	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/10/27	04:31	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/09/08	23:13	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/08/30	04:34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/08/03	02:40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/08/01	02:54	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/26	05:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/26	05:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/25	23:33	GlobeNewswire Inc.	Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/18	23:45	GlobeNewswire Inc.	Nymox Reports on U.S. Patent Issuances	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/13	23:16	GlobeNewswire Inc.	Nymox Update	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/13	06:08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/12	22:30	GlobeNewswire Inc.	Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/08	06:02	GlobeNewswire Inc.	NYMOX Update	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/07/06	07:11	GlobeNewswire Inc.	Nymox Delisting from NASDAQ	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/06/30	06:15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/06/30	06:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/06/30	05:25	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/06/30	05:24	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/06/28	06:15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/06/26	23:28	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/05/19	05:14	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/05/13	05:53	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/05/10	23:00	GlobeNewswire Inc.	Nymox Provides Current Update	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/04/03	22:30	GlobeNewswire Inc.	Nymox Provides Corporate Update	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/04/01	05:25	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/03/21	23:00	GlobeNewswire Inc.	Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer	NASDAQ:NYMX	Nymox Pharmaceutical Corp
2023/03/15	22:30	GlobeNewswire Inc.	Nymox Officially Granted Extension to Regain Listing Requirements	NASDAQ:NYMX	Nymox Pharmaceutical Corp

검색 관련기사 보기:NASDAQ:NYMX

1 2 3 4 5 6 7 8 9 10 다음 >>

Gold vs US Dollar

Health Care Select Sector

Verizon Communications

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관